CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in GNLX — GENELUX Corp

CIK 884546 SAN FRANCISCO, CA

Position in GNLX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$75,319

+$14,819 QoQ

Shares Held

25,023

+0.1% QoQ

Ownership

0.055%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#37

of 72 holders

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. GNLX ranks #293 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,041,282	$1,013,966,007
2	REGN	Regeneron Pharmaceuticals, Inc.	846,306	$527,705,642
3	RVMD	Revolution Medicines, Inc.	1,917,025	$359,020,441
4	MRNA	Moderna, Inc.	4,838,884	$338,867,045
5	ALNY	Alnylam Pharmaceuticals, Inc.	755,377	$227,391,137
6	INCY	Incyte Corp	1,692,439	$191,854,884
7	RPRX	Royalty Pharma plc	3,083,528	$172,893,414
8	CYTK	Cytokinetics Inc	1,565,781	$133,388,883

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$75,319	25,023	+0.1%	Shares	Sole	2026-08-14
2026-03-31	$60,500	25,000	0.0%	Shares	Sole	2026-05-15
2025-12-31	$109,000	25,000	0.0%	Shares	Sole	2026-02-13
2025-09-30	$105,000	25,000	0.0%	Shares	Sole	2025-11-10
2025-06-30	$71,750	25,000	0.0%	Shares	Sole	2025-08-12
2025-03-31	$67,500	25,000	-72.3%	Shares	Sole	2025-09-15
2024-06-30	$176,090	90,303	-40.8%	Shares	Sole	2024-08-12
2024-03-31	$980,632	152,509	+1.9%	Shares	Sole	2024-05-09
2023-12-31	$2,095,952	149,604	+1.4%	Shares	Sole	2024-02-06
2023-09-30	$3,614,944	147,609	+689.4%	Shares	Sole	2023-11-08
2023-06-30	$611,864	18,700	+23.2%	Shares	Sole	2023-08-10
2023-03-31	$420,982	15,176	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.